REGULATED PRESS RELEASE published on 03/27/2024 at 21:19, 2 years 6 months ago Covivio - Conditions of availability of preparatory documents to the Combined Ordinary and Extraordinary General Meeting of 17 April 2024 Covivio announces availability of preparatory documents for the Combined Ordinary and Extraordinary General Meeting on 17 April 2024. Shareholders can access documents at the company's office or website Shareholders Covivio General Meeting Preparatory Documents Availability
BRIEF published on 03/19/2024 at 19:40, 2 years 6 months ago Covivio Announces Availability of 2023 Universal Registration Document AMF Covivio Corporate Governance Universal Registration Document 2023 Financial Report
REGULATED PRESS RELEASE published on 03/19/2024 at 19:35, 2 years 6 months ago Covivio - Conditions of availability of the 2023 Universal Registration Document Covivio announces availability of its 2023 Universal Registration Document in ESEF format for public access, including financial reports and governance details Governance Covivio Financial Reports Universal Registration Document ESEF Format
BRIEF published on 02/22/2024 at 07:45, 2 years 7 months ago Strategic Strengthening of Covivio in the Hotel Sector Acquisition Covivio Hotel Real Estate Hotel Market Tourism Growth
REGULATED PRESS RELEASE published on 02/22/2024 at 07:45, 2 years 7 months ago Covivio - Major reinforcement in hotels Covivio reinforces its position in the hotel sector by acquiring Generali's stake in Covivio Hotels, signaling growth in the European hotel market Acquisition Covivio Hotels Growth Prospects European Hotel Market
REGULATED PRESS RELEASE published on 02/15/2024 at 19:15, 2 years 7 months ago Covivio - 2023 annual results: Ahead of targets and continued growth in recurring earnings
REGULATED PRESS RELEASE published on 01/18/2024 at 18:46, 2 years 8 months ago Covivio: half-year liquidity contract reporting at 31 December 2023 The half-yearly report on the COVIVIO liquidity contract reveals the allocation of resources to the liquidity account, the negotiations during the second semester 2023, and the daily report for the period from 01/07/2023 to 31/12/2023. COVIVIO, a leading real estate player at the European level, emphasizes sustainable relationships, well-being, and responsible performance as part of its Purpose. Its shares listed in the Euronext Paris A compartment are included in various indices and hold multiple awards and ratings. COVIVIO Liquidity Contract Real Estate Expertise European Culture Sustainable Relationships Responsible Performance
REGULATED PRESS RELEASE published on 11/07/2023 at 19:05, 2 years 11 months ago Covivio and AccorInvest enter into exclusive negotiations with a view to consolidating their hotel properties and business assets
REGULATED PRESS RELEASE published on 10/20/2023 at 18:00, 2 years 11 months ago Transfer of Covivio's liquidity contract by EXANE to BNP PARIBAS ARBITRAGE
REGULATED PRESS RELEASE published on 10/19/2023 at 18:00, 2 years 11 months ago Covivio - Activity at end-September 2023: Stronger balance sheet and revenues up +7% like-for-like
Published on 10/12/2026 at 22:01, 8 hours 44 minutes ago Fermi Announces Third Quarter 2026 Earnings Release and Call Date
Published on 10/12/2026 at 15:00, 15 hours 45 minutes ago Shelfie-Tech Announces Closing of Private Placement
Published on 10/12/2026 at 13:00, 17 hours 45 minutes ago U.S. Energy Secretary Chris Wright, EXIM Chairman John Jovanovic, Nebraska Governor Jim Pillen, Senators Deb Fischer and Pete Ricketts, and Congressman Adrian Smith to Visit NioCorp's Critical Minerals Mine Site
Published on 10/10/2026 at 04:45, 3 days 2 hours ago Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Published on 10/10/2026 at 02:03, 3 days 4 hours ago BrandPilot AI Announces Closing of Previously Announced Debt Settlement
Published on 10/13/2026 at 06:00, 45 minutes ago Formycon and Zydus: FYB206 Becomes First Publicly Announced Keytruda® Biosimilar Accepted for Review by FDA
Published on 10/12/2026 at 20:30, 10 hours 15 minutes ago Correction of a release from 29.09.2026 18:15 CET/CEST - Multi Units Luxembourg: NOTICE TO THE SHAREHOLDERS
Published on 10/12/2026 at 20:30, 10 hours 15 minutes ago Correction of a release from 02.10.2026 14:59 CET/CEST - Multi Units Luxembourg: NOTICE TO THE SHAREHOLDERS
Published on 10/12/2026 at 20:05, 10 hours 39 minutes ago SPARX Global Randomized Controlled Trial by Translumina Initiated to Advance Evidence for Drug-Coated Balloons in Complex Coronary Disease
Published on 10/12/2026 at 17:59, 12 hours 45 minutes ago Reporting on share buyback transactions carried out between October 7 and October 9, 2026
Published on 10/12/2026 at 17:45, 13 hours ago Declaration of transactions on own shares from October 5, 2026 to October 11, 2026
Published on 10/12/2026 at 15:47, 14 hours 57 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of September 30, 2026
Published on 10/12/2026 at 15:12, 15 hours 32 minutes ago Statement of transactions in own shares from October 5, 2026 to October 9, 2026